<?xml version="1.0" encoding="UTF-8"?>
<org.eclipse.epf.uma:ContentDescription xmi:version="2.0" xmlns:xmi="http://www.omg.org/XMI" xmlns:org.eclipse.epf.uma="http://www.eclipse.org/epf/uma/1.0.6/uma.ecore" xmlns:rmc="http://www.ibm.com/rmc" rmc:version="7.5.1" xmlns:epf="http://www.eclipse.org/epf" epf:version="1.5.1" xmi:id="-ae_VlOjOrQytVKGs5pTvaQ" name="new_concept,_Rnh5ELS7EeGqmsDJBiIzJg" guid="-ae_VlOjOrQytVKGs5pTvaQ" changeDate="2012-11-08T10:17:08.284-0800" version="7.5.1">
  <mainDescription>&lt;p>&#xD;
    Design Control is an approach to systems development that supports systematic assessment of design as an integral part&#xD;
    of development. It is a fundamental concept of the US Federal Food and Drug Administration (FDA) guidance for medical&#xD;
    device manufacturers and is compatible with the requirements from other regulatory bodies. The FDAâ€™s approach is&#xD;
    documented in its Quality System Requirements, which are harmonized with ISO 13485:1996 (The FDA is updating this to&#xD;
    the current version of the ISO 13485 standard, but we have no information on when this might be available). Design&#xD;
    Control can be applied to any development approach or life cycle.&#xD;
&lt;/p>&#xD;
&lt;h4>&#xD;
    FDA Statements&#xD;
&lt;/h4>&#xD;
&lt;p>&#xD;
    The specific statements in the FDA Guidance are:&#xD;
&lt;/p>&#xD;
&lt;p>&#xD;
    (a)General. (1) Each manufacturer of any class III or class II device, and the class I devices listed in paragraph&#xD;
    (a)(2) of this section, shall establish and maintain procedures to control the design of the device in order to ensure&#xD;
    that specified design requirements are met.&#xD;
&lt;/p>&#xD;
&lt;p>&#xD;
    (2) The following class I devices are subject to design controls: (i) Devices automated with computer software; and&#xD;
    (ii) The devices listed in the following chart.&#xD;
&lt;/p>&#xD;
&lt;table title=&quot;&quot; border=&quot;1&quot; cellspacing=&quot;0&quot; cellpadding=&quot;2&quot; width=&quot;85%&quot;>&#xD;
    &lt;tbody>&#xD;
        &lt;tr>&#xD;
            &lt;th abbr=&quot;&quot; scope=&quot;col&quot;>&#xD;
                Section&#xD;
            &lt;/th>&#xD;
            &lt;th abbr=&quot;&quot; scope=&quot;col&quot;>&#xD;
                Device&#xD;
            &lt;/th>&#xD;
        &lt;/tr>&#xD;
        &lt;tr>&#xD;
            &lt;td>&#xD;
                868.6810&#xD;
            &lt;/td>&#xD;
            &lt;td>&#xD;
                Catheter, Tracheobronchial Suction&#xD;
            &lt;/td>&#xD;
        &lt;/tr>&#xD;
        &lt;tr>&#xD;
            &lt;td>&#xD;
                878.4460&#xD;
            &lt;/td>&#xD;
            &lt;td>&#xD;
                Glove, Surgeon's&#xD;
            &lt;/td>&#xD;
        &lt;/tr>&#xD;
        &lt;tr>&#xD;
            &lt;td>&#xD;
                880.6760&#xD;
            &lt;/td>&#xD;
            &lt;td>&#xD;
                Restraint, Protective&#xD;
            &lt;/td>&#xD;
        &lt;/tr>&#xD;
        &lt;tr>&#xD;
            &lt;td>&#xD;
                892.5650&#xD;
            &lt;/td>&#xD;
            &lt;td>&#xD;
                System, Applicator, Radionuclide, Manual&#xD;
            &lt;/td>&#xD;
        &lt;/tr>&#xD;
        &lt;tr>&#xD;
            &lt;td>&#xD;
                892.5740&#xD;
            &lt;/td>&#xD;
            &lt;td>&#xD;
                Source, Radionuclide Teletherapy&#xD;
            &lt;/td>&#xD;
        &lt;/tr>&#xD;
    &lt;/tbody>&#xD;
&lt;/table>&#xD;
&lt;h4>&#xD;
    &lt;br />&#xD;
    Activities and Artifacts&#xD;
&lt;/h4>&#xD;
&lt;p>&#xD;
    Design Control consists of a number of activities and artifact types.&#xD;
&lt;/p>&#xD;
&lt;p>&#xD;
    Activities: Design and Development Planning, Review Design, Verify Design, Validate Design, Transfer Design, and Manage&#xD;
    Change.&#xD;
&lt;/p>&#xD;
&lt;p>&#xD;
    Artifact types: Design Input, Design Output, and Design History File.&#xD;
&lt;/p>&#xD;
&lt;p>&#xD;
    Notice that many processes, for example those involved in creating Design Output, are not specified. Design Control&#xD;
    leaves those up to the manufacturer to define. Design Control is concerned with ensuring that outcomes are appropriate,&#xD;
    not with how they are produced. This is why it is independent of development life cycle.&#xD;
&lt;/p>&#xD;
&lt;p>&#xD;
    The following figure shows how these fit together. The waterfall lifecycle is used merely as an exemplar:&#xD;
&lt;/p>&#xD;
&lt;p>&#xD;
    &lt;img style=&quot;WIDTH: 606px; HEIGHT: 350px&quot; alt=&quot;&quot; src=&quot;./resources/dsgnCntrl1.jpg&quot; width=&quot;600&quot; height=&quot;459&quot; />&#xD;
&lt;/p>&#xD;
&lt;p>&#xD;
    The Design Process would generally have multiple levels (the highlighted blue box is recursive), the Design Output from&#xD;
    one level is the Design Input to the next, until it is sufficiently refined to allow production of the device (or&#xD;
    component of the device). Reviews potentially occur in all stages, for all artifacts (though the FDA Guidance only&#xD;
    mandates one review. Validation is used to show that the delivered device satisfies the requirements and Verification&#xD;
    shows that the Design Output satisfies the Design Input. This is shown at one level in the following figure:&#xD;
&lt;/p>&#xD;
&lt;p>&#xD;
    &lt;img style=&quot;WIDTH: 605px; HEIGHT: 377px&quot; alt=&quot;&quot; src=&quot;./resources/dsgnCntrl2.jpg&quot; width=&quot;600&quot; height=&quot;542&quot;&#xD;
    usemap=&quot;#map1340806707820&quot; />&lt;map id=&quot;map1340806707820&quot; name=&quot;map1340806707820&quot;>&#xD;
    &lt;/map>&#xD;
&lt;/p>&#xD;
&lt;p>&#xD;
    See related material for details of the work products and tasks.&#xD;
&lt;/p>&#xD;
&lt;h4>&#xD;
    References&#xD;
&lt;/h4>&#xD;
&lt;ul>&#xD;
    &lt;li>&#xD;
        FDA Design Control Guidance for Medical Device Manufacturers: &#xD;
        &lt;ul>&#xD;
            &lt;li>&#xD;
                &lt;a&#xD;
                href=&quot;http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm070627.htm&quot;>http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm070627.htm&lt;/a>&#xD;
            &lt;/li>&#xD;
            &lt;li>&#xD;
                &lt;a&#xD;
                href=&quot;http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm070642.pdf&quot;>http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm070642.pdf&lt;/a>&#xD;
            &lt;/li>&#xD;
        &lt;/ul>&#xD;
    &lt;/li>&#xD;
    &lt;li>&#xD;
        Section 820.30(a) of FDA Quality System Regulation&#xD;
    &lt;/li>&#xD;
    &lt;li>&#xD;
        ISO 9001:1994&#xD;
    &lt;/li>&#xD;
    &lt;li>&#xD;
        ISE/DIS 13485 Section 4.4.1 General&#xD;
    &lt;/li>&#xD;
&lt;/ul></mainDescription>
</org.eclipse.epf.uma:ContentDescription>
